LATS1/2 function as tumor suppressors in other contexts23 and luminal mammary cells harbor a potential source for multiple breast cancer subtypes24, so we sought to test the impact of LATS1/2 inactivation in the luminal mammary epithelium in vivo. The gene discussed is LATS1; the disease is breast carcinoma.